Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series

BACKGROUND: Post-vaccination BCG disease typically attests to underlying inborn errors of immunity (IEIs), with the highest rates of complications in patients with Mendelian susceptibility to mycobacterial disease (MSMD). However, therapeutic protocols for the management of BCG-osis (disseminated) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdaviani, Seyed Alireza, Fallahi, Mazdak, Jamee, Mahnaz, Marjani, Majid, Tabarsi, Payam, Moniri, Afshin, Farnia, Parisa, Daneshmandi, Zahra, Parvaneh, Nima, Casanova, Jean-Laurent, Bustamante, Jacinta, Mansouri, Davood, Velayati, Ali Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889629/
https://www.ncbi.nlm.nih.gov/pubmed/35232430
http://dx.doi.org/10.1186/s12941-022-00500-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889629/
https://www.ncbi.nlm.nih.gov/pubmed/35232430
http://dx.doi.org/10.1186/s12941-022-00500-y

Ejemplares similares